Webinar: After the Battlefield: Veterans, Chronic Pain & Psychedelic Medicines
This webinar will explore chronic pain, trauma, and mental health in veterans, with a focus on psychedelic therapies, access to care, and treatment options.
Veterans experience high rates of chronic pain, PTSD, and other mental health conditions, often with overlapping symptoms that complicate treatment and recovery. Despite access to conventional therapies, many continue to experience persistent pain, functional limitations, and unmet healthcare needs. This webinar will explore the intersection of chronic pain, trauma, and mental health among veterans, with a focus on the emerging role of psychedelic-assisted therapies. The discussion will examine current treatment approaches, the potential benefits and limitations of psychedelics, and the challenges veterans face in navigating healthcare systems and accessing emerging therapies. Particular attention will be given to treatment accessibility, Veterans Affairs coverage, gaps in existing services, and opportunities to improve care for veterans living with complex and often overlapping conditions.
After the Battlefield: Veterans, Chronic Pain & Psychedelic Medicines
Lynn Watkins
Court Wing
Gordon Hurley
Jagpaul Deol
Describe the relationship between chronic pain, PTSD, and other mental health conditions commonly experienced by veterans.
Discuss the emerging role of psychedelic-assisted therapies in addressing chronic pain and co-occurring mental health conditions, including potential benefits and limitations.
Identify barriers to accessing psychedelic-assisted therapies, including regulatory restrictions, treatment costs, Veterans Affairs coverage, and healthcare system limitations.
Examine gaps in existing treatment approaches and opportunities to improve access to comprehensive, patient-centred care for veterans living with chronic pain and trauma.
Recognize the importance of incorporating lived experience into discussions of treatment effectiveness, healthcare policy, and the development of emerging therapeutic services.